The content on this site is intended for healthcare professionals only
Dr David Martinez Perez presents his talk about breast and emerging indications for IORT.
He explains the key topics of his presentation which include the IORT treatment options, potential clinical outcomes for breast cancer patients and a variety of clinical studies that have investigated the use of IORT.
Dr Martinez Perez concludes by looking toward the potential future developments of this field.
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
The advantages of IORT for early breast cancer treatment
The pros and cons of breast IORT and ultra hypofractionation (FR)
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
Global adoption of single-shot targeted IORT for breast cancer
IORT at the Asian Hospital and Medical Center
The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation therapy: long-term local control and survival
Insights from TARGIT-A trial of targeted IORT during lumpectomy for breast cancer
